CL
CRDF icon

CSS LLC’s Cardiff Oncology CRDF Stock Holding History

CSS LLC’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,100
Closed -$59K – 980
2022
Q3 		$59K Sell
38,100
-79,400
-68% -$191K ﹤0.01% 866
2022
Q2 		$258K Buy
117,500
+39,100
+50% +$65.5K 0.01% 746
2022
Q1 		$194K Buy
78,400
+32,400
+70% +$115K 0.01% 850
2021
Q4 		$277K Hold
46,000
– – 0.01% 838
2021
Q3 		$306K Buy
+46,000
New +$289K 0.01% 769
2021
Q1 		– Sell
-16,800
Closed -$302K – 951
2020
Q4 		$302K Sell
16,800
-13,100
-44% -$230K 0.01% 566
2020
Q3 		$423K Buy
+29,900
New +$197K 0.02% 447

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CSS LLC's CRDF Position: Q4 2022 in Review

CSS LLC sold out of Cardiff Oncology (CRDF) in Q4 2022, closing a stake of 35,920 shares — an estimated $55K sold.

CSS LLC first reported a position in CRDF in Q4 2020 and held it in 7 quarters. The position peaked at $224K in Q2 2021. 60 funds tracked by Wall St. Rank hold CRDF as of Q4 2022.

  • CSS LLC reported no remaining Cardiff Oncology position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 35,920 Cardiff Oncology shares in Q4 2022, an estimated $55K.
  • CSS LLC first reported a position in Cardiff Oncology in Q4 2020 and held it in 7 quarters.
  • CSS LLC's Cardiff Oncology position peaked at $224K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.